|
LPIN2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.051600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.147600E-02 |
| Normal-vs-Stage2 |
2.196100E-02 |
| Normal-vs-Stage3 |
1.086800E-01 |
| Normal-vs-Stage4 |
1.049380E-01 |
| Stage1-vs-Stage2 |
2.095000E-01 |
| Stage1-vs-Stage3 |
8.834000E-01 |
| Stage1-vs-Stage4 |
7.700200E-01 |
| Stage2-vs-Stage3 |
2.684000E-01 |
| Stage2-vs-Stage4 |
4.135200E-01 |
| Stage3-vs-Stage4 |
8.567600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.019800E-02 |
| Normal-vs-AfricanAmerican |
7.389600E-01 |
| Normal-vs-Asian |
5.258000E-01 |
| Caucasian-vs-AfricanAmerican |
1.574750E-01 |
| Caucasian-vs-Asian |
4.552600E-01 |
| AfricanAmerican-vs-Asian |
4.396000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.495560E-02 |
| Normal-vs-Female |
9.700200E-02 |
| Male-vs-Female |
1.323400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.994420E-01 |
| Normal-vs-Age(41-60Yrs) |
1.293190E-01 |
| Normal-vs-Age(61-80Yrs) |
7.775500E-03 |
| Normal-vs-Age(81-100Yrs) |
1.519990E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.103600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.670000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.223000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.058790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.561400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.828400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.657800E-01 |
| Classical-VS-Follicular |
3.92060000020678E-08 |
| Classical-VS-Other |
5.278300E-02 |
| Classical-VS-Normal |
6.255400E-01 |
| Tall-VS-Follicular |
4.882600E-03 |
| Tall-VS-Other |
9.641800E-02 |
| Tall-VS-Normal |
4.446600E-01 |
| Follicular-VS-Other |
8.975600E-01 |
| Follicular-VS-Normal |
1.9981999999974E-05 |
| Other-VS-Normal |
2.412100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.537600E-03 |
| Normal-vs-N1 |
6.902200E-03 |
| N0-vs-N1 |
4.731000E-01 |
|
|
